Research Overview: VIAGRON 100 Hilma Biocare
VIAGRON 100 Hilma Biocare is a phosphodiesterase type 5 (PDE5) inhibitor containing sildenafil citrate as its active pharmaceutical ingredient. This compound has established itself as a valuable research tool for investigating vascular mechanisms, nitric oxide pathways, and cardiovascular physiology in controlled laboratory settings. Researchers at Stroid UK Shop utilise this compound to examine endothelial function and smooth muscle relaxation responses across various experimental models.
Laboratory Research Applications
Scientific investigations with VIAGRON 100 focus primarily on vascular research and cardiovascular studies. Research teams examine its effects on cyclic guanosine monophosphate (cGMP) pathways, investigating how PDE5 inhibition influences cellular signalling mechanisms. The compound proves particularly valuable for studies examining endothelial dysfunction, pulmonary arterial pressure responses, and nitric oxide-dependent vasodilation processes. Laboratories studying post cycle therapy compounds often incorporate sildenafil citrate research to understand its broader physiological implications beyond cardiovascular applications.
Research protocols frequently investigate VIAGRON 100’s interaction with other molecular pathways, particularly in combination studies alongside selective androgen receptor modulators and research peptides to evaluate synergistic effects on cellular metabolism and vascular function. These comprehensive studies contribute to understanding complex physiological interactions in controlled experimental environments.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Concentration | 100mg per tablet |
| Manufacturer | Hilma Biocare |
| Molecular Formula | C₂₂H₃₀N₆O₄S·C₆H₈O₇ |
| Molecular Weight | 666.7 g/mol |
| CAS Number | 171599-83-0 |
Research Compliance Statement
VIAGRON 100 Hilma Biocare is manufactured exclusively for in-vitro research applications and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety procedures, and regulatory compliance when conducting studies with this material.
